Avalon Technologies Limited (AVALON) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Cofacto Research Published November 07, 2026 6 min read

Avalon Technologies is a fully integrated Electronics Manufacturing Services company building complex box-build solutions for industrial, mobility, clean energy and semiconductor equipment end-markets, and it enters this quarter on the back of eight consecutive quarters of sequential revenue improvement. The print will speak to whether the raised FY27 revenue growth guidance of 26-30% holds, and how the newly signed Zollner Elektronik AG JV and the new Chennai plant ramp shape the growth path.

Quick Details
Results dateNovember 12, 2026
QuarterQ2 FY 2026-2027
Previous quarter revenueRs. 484 Cr
Previous quarter PATRs. 35 Cr
Previous quarter EBITDA margin12.0%
Market capRs. 12,667.89 Cr
CMPRs. 1,893.6

Avalon Technologies Limited Q2 Results Date and Time

The board will meet on November 12, 2026 to approve the Unaudited Standalone & Consolidated results for Q2/H1 FY27.

The earnings call for Q2/H1 FY27 is scheduled for Friday, November 13, 2026 at 15:30 IST.

What to expect from Avalon Technologies Limited's Q2 FY27 results

The quarter is a test of whether Avalon's raised FY27 revenue growth guidance of 26-30% survives contact with a second straight print, after Q1 FY27 revenue of Rs. 484 Cr grew 49.8% YoY. The demand stack entering the quarter was favourable on every leg: the US ISM Manufacturing PMI held in the mid-50s through July-September (55.6, 54.6, 54.5) with the Backlog of Orders index up 4.6 points to 56.4 in September, and India's electronics IIP print ran at +19.3% YoY in July 2026.

Avalon enters with an order book of Rs. 2,208 Cr as of June 30, 2026 (+23.4% YoY, executable over roughly 14 months), and the rupee's slide to 95.95 by September 28 adds a translation tailwind to a mix where 59% of Q1 FY27 revenue came from US-market customers.

On margins, component-cost inflation ran hot through the quarter — memory prices up 40-105% and PCB raw materials like low-bromine epoxy resin up roughly 70% over eight-nine months — but Avalon's model recovers commodity increases from customers within the same quarter, so the watch-point is gross margin holding inside the guided 33-35% band (34.7% in Q1 FY27) rather than expanding.

The company-flagged risk remains program timing, with the CMD noting large program starts 'may happen in February of next year or customer may delay to April', which is why guidance is framed conservatively. The call should also cover the US manufacturing loss trajectory from about Rs. 4 Cr in Q1 FY27 against the guided EBITDA breakeven by the latter part of FY27.

Key Things To Watch

FY27 revenue guidance and doubling targets: Whether management holds, raises or trims the raised band after a Q1 that grew well above it.

  • FY27 revenue growth guidance of 26-30% (raised from 24-27% on the Q1 FY27 call) — watch the H1 FY27 run-rate against the band and whether the 'conservative due to program timing' framing recurs
  • Progress vs the ~Rs. 1,725 Cr FY27 doubling target (tracking about a year ahead as of the Q4 FY26 call) and the ~Rs. 3,200 Cr by FY29 target from the FY26 base of Rs. 1,603 Cr

US manufacturing breakeven path: The US operations remain loss-making, with breakeven guided but not yet delivered.

  • Quarterly US loss trajectory from ~Rs. 4 Cr in Q1 FY27 (vs ~Rs. 9 Cr PAT losses in Q1/Q2 FY26) against the guided US EBITDA breakeven by the latter part of FY27, followed by PAT breakeven
  • US share of sales vs the 19-23% planning range; Q1 FY27 India manufacturing was 72% of revenue with 16.7% India EBITDA margin

Chennai new plant and capex cadence: Confirmation of the Q2 FY27 production start and spending against the annual guide.

  • Confirmation that the new Chennai plant commenced production in Q2 FY27 as guided, plus capex cadence vs the Rs. 50-60 Cr annual guide (FY26 actual capex Rs. 53.64 Cr)
  • Execution on the 99-year lease for 25.08 acres at SIPCOT Industrial Park, Oragadam, executed October 8, 2026 for future capacity

Zollner JV and warrant issue: The quarter's defining corporate event moves to its shareholder-vote stage.

  • Integration updates on Zollner Avalon Private Limited (incorporated October 19, 2026; Zollner 51% / Avalon 49%) and the new Health Care & Life Sciences and Test & Measurement verticals
  • The November 21, 2026 EGM vote on the preferential issue of up to 19,37,808 warrants at Rs. 2,193.20 each, aggregating ~Rs. 425 Cr, with e-voting November 18-20

Order book, margins and promoter reclassification: The structural questions analysts have pressed on for three quarters.

  • Whether the order book moves decisively above the ~Rs. 2,000-2,200 Cr range — its ~23% YoY growth has trailed revenue growth for three quarters, which management attributes to rolling-PO accounting — and any update on the Rs. 3,465 Cr of long-term contracts executable 3 to 15 years
  • Gross margin within the 33-35% guided band, EBITDA margin path beyond 12.0%, box-build share beyond 60%, and net working capital within the 120-130 day range (117 days at Jun-26)
  • Outcome of the Board's November 12, 2026 consideration of the Regulation 31A request to reclassify the residual 9.42% holding of the Bhaskar Srinivasan promoter branch from 'Promoter' to 'Public' — no share sale attached at this stage

Frequently Asked Questions

Why is Avalon's order book growing slower than its revenue?

Management's explanation is that long-term and rolling-PO orders are counted only at current rolling amounts, so a direct comparison with revenue growth is misleading. New programs may also show only prototype orders until volume purchase orders land.

When will Avalon's US manufacturing operations break even?

Management has guided for US manufacturing EBITDA breakeven by the latter part of FY27 / end of the fiscal year, followed by PAT breakeven. The US loss narrowed to about Rs. 4 Cr in Q1 FY27 from roughly Rs. 9 Cr PAT losses in Q1/Q2 FY26.

Why does Avalon guide conservatively on revenue growth?

The CMD has said 'we are conservative' because large program start dates are controlled by customers and can slip — for example from February of next year to April. FY26 showed the pattern in reverse: guidance was raised twice (23-25% initially, then 28-30%, then ~40%) and actual growth came in at 46%.

How does Avalon keep working capital in check despite rapid growth?

Net working capital stood at 117 days at June 2026, within the guided 120-130 day range, with inventory days falling to 94 from 104. Management attributes this to continuous efforts across inventory, receivables and payables, while cautioning that new programs may raise working capital initially.

What is the Zollner JV and how is it funded?

Avalon executed a joint venture agreement with Zollner Elektronik AG on September 3, 2026, forming Zollner Avalon Private Limited with Zollner at 51% and Avalon at 49%, with Avalon holding a call option to go to 51% majority. Zollner will subscribe up to 19,37,808 warrants at Rs. 2,193.20 each, aggregating about Rs. 425 Cr, with the EGM scheduled for November 21, 2026.

Disclaimer: This earnings preview is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now